Precigen, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
PGEN on Nasdaq
Industry
Pharmaceutical Preparations
Location
20374 Seneca Meadows Parkway, Germantown, MD

Insiders trading volume in the past year

Precigen, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Randal J. Kirk Director, 10%+ Owner $202M +$20M +11% Mar 13, 2025
Ares Trading S.A. 10%+ Owner $29.1M Oct 12, 2021
Helen Sabzevari President and CEO, Director $5.46M Apr 17, 2025
Fred Hassan Director $2.01M Mar 13, 2025
Steven Frank Director $1.98M Mar 13, 2025
Cesar L. Alvarez Director $1.21M Mar 13, 2025
James S. Turley Director $1.04M Mar 13, 2025
Donald P. Lehr Chief Legal Officer $1.03M Apr 17, 2025
Vinita D. Gupta Director $1M Mar 13, 2025
Jeffrey B. Kindler Director $906K Mar 13, 2025
Dean J. Mitchell Director $845K Mar 14, 2024
Harry Thomasian Jr. Chief Financial Officer $729K Apr 17, 2025
Rutul R. Shah Chief Operating Officer $677K Apr 17, 2025
Robert B. Shapiro Director $657K Mar 9, 2023
Jeffrey T. Perez SVP, IP Affairs $632K +$50K +8.6% Aug 9, 2024
Nancy H. Agee Director $212K Mar 13, 2025
Phil Tennant Chief Commercial Officer $136K Apr 17, 2025
James V. Lambert Ex. Dir. Fin., PGEN Ther. Inc. $17.4K Jun 10, 2021

Recent Insider Transactions by Companies or Individuals for Precigen, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.